Strategics join $35M A round for Surface Oncology

Cancer immunotherapy play Surface Oncology Inc. (Cambridge, Mass.) raised $35 million in a series A round led by

Read the full 182 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE